94 related articles for article (PubMed ID: 1406472)
1. [Refractory anemia with 5q--anomaly. Clinical picture and follow-up of seven patients].
May D; Becher R
Med Klin (Munich); 1992 Aug; 87(8):408-11. PubMed ID: 1406472
[TBL] [Abstract][Full Text] [Related]
2. [5q anomaly in myelodysplasia and acute myelocytic leukemia].
Robak T
Acta Haematol Pol; 1990; 21(2):235-42. PubMed ID: 2151871
[No Abstract] [Full Text] [Related]
3. [The 5q syndrome--a chromosome aberration with characteristic hematologic picture: preleukemia? Literature review and description of a personal case].
Mueller RA; Auf der Maur P; Beck EA; Deubelbeiss K; Bucher U
Schweiz Med Wochenschr; 1982 Feb; 112(7):242-52. PubMed ID: 7071578
[TBL] [Abstract][Full Text] [Related]
4. Peripheral blood picture in primary hypocellular refractory anemia and idiopathic acquired aplastic anemia: an additional tool for differential diagnosis.
Elghetany MT; Hudnall SD; Gardner FH
Haematologica; 1997; 82(1):21-4. PubMed ID: 9107077
[TBL] [Abstract][Full Text] [Related]
5. Leukemic transformation in patients with 5Q- and additional abnormalities.
Larripa I; Acevedo S; Palau Nagore MV; Bengiò R; Mondini N; Slavutsky I
Haematologica; 1991; 76(5):363-7. PubMed ID: 1806438
[TBL] [Abstract][Full Text] [Related]
6. Dihydrofolate reductase activity in the erythroblasts of patients with 5q- syndrome.
Nano R; Invernizzi R; Pecci A; Civallero M; Gerzeli G
Haematologica; 2000 Jul; 85(7):765-6. PubMed ID: 10897132
[No Abstract] [Full Text] [Related]
7. Clonal evolution in a transforming 5q- syndrome.
Kandioler D; Krieger O; Nowotny H; Lutz D
Leukemia; 1994 Apr; 8(4):711-2. PubMed ID: 8152269
[No Abstract] [Full Text] [Related]
8. [Morphological changes in peripheral blood and bone marrow in patients with myelodysplastic syndromes].
Mariańska B; Apel D; Maj S
Acta Haematol Pol; 1991; 22(1):48-53. PubMed ID: 1823967
[TBL] [Abstract][Full Text] [Related]
9. [The 5q- syndrome associated with marked erythroid hypoplasia and Coombs test positive hemolysis].
Ohno T; Hishizawa M; Sugiyama T; Mizumoto T; Furukawa H
Rinsho Ketsueki; 1999 Jun; 40(6):499-504. PubMed ID: 10422288
[TBL] [Abstract][Full Text] [Related]
10. Myelodysplastic syndromes associated with interstitial deletion of chromosome 5q: clinicopathologic correlations and new insights from the pre-lenalidomide era.
Holtan SG; Santana-Davila R; Dewald GW; Khetterling RP; Knudson RA; Hoyer JD; Chen D; Hanson CA; Porrata L; Tefferi A; Steensma DP
Am J Hematol; 2008 Sep; 83(9):708-13. PubMed ID: 18634051
[TBL] [Abstract][Full Text] [Related]
11. The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia.
Cermák J; Belicková M; Krejcová H; Michalová K; Zilovcová S; Zemanová Z; Brezinová J; Sieglová Z
Leuk Res; 2005 Apr; 29(4):371-9. PubMed ID: 15725470
[TBL] [Abstract][Full Text] [Related]
12. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the 5q- breakpoint in an acute nonlymphocytic leukemia patient using pulsed-field gel electrophoresis.
Thornton DE; Theil K; Payson R; Balcerzak SP; Chiu IM
Am J Med Genet; 1991 Dec; 41(4):557-65. PubMed ID: 1723247
[TBL] [Abstract][Full Text] [Related]
14. Carcinoma of pancreas associated with the 5q-syndrome.
Berrebi A; Vorst E; Chemke J; Pfefferman R
Anticancer Res; 1984; 4(3):205-7. PubMed ID: 6465858
[TBL] [Abstract][Full Text] [Related]
15. 5q- and disordered haematopoiesis.
Bunn HF
Clin Haematol; 1986 Nov; 15(4):1023-35. PubMed ID: 3552346
[No Abstract] [Full Text] [Related]
16. Cytogenetic analysis in patients with myelodysplastic syndrome.
Hu N; Bian M
Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(3):135-9. PubMed ID: 2098765
[TBL] [Abstract][Full Text] [Related]
17. Molecular definition of chromosome arm 5q deletion end points and detection of hidden aberrations in patients with myelodysplastic syndromes and isolated del(5q) using oligonucleotide array CGH.
Evers C; Beier M; Poelitz A; Hildebrandt B; Servan K; Drechsler M; Germing U; Royer HD; Royer-Pokora B
Genes Chromosomes Cancer; 2007 Dec; 46(12):1119-28. PubMed ID: 17823930
[TBL] [Abstract][Full Text] [Related]
18. Tetraploidy and 5q deletion in myelodysplastic syndrome: a case report.
Znoyko I; Stuart RK; Ellingham T; Winters J; Wolff DJ; Quigley DI
Cancer Genet Cytogenet; 2008 May; 183(1):64-8. PubMed ID: 18474300
[TBL] [Abstract][Full Text] [Related]
19. Late appearing 5q--marker in refractory anemia.
Heim S; Billström R; Kristoffersson U; Mandahl N; Mitelman F
Cancer Genet Cytogenet; 1987 Jan; 24(1):159-62. PubMed ID: 3466668
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetic studies in 32 patients with myelodysplastic syndrome: insights to specific chromosomal abnormalities and prognosis.
Taniwaki M; Horiike S; Inazawa J; Nishida K; Misawa S; Takino T; Abe T
Jpn J Clin Oncol; 1987 Jun; 17(2):141-50. PubMed ID: 3613138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]